Skip to main navigation Skip to search Skip to main content

Maximum intravenous alteplase dose for obese stroke patients is not associated with greater likelihood of worse outcomes

Research output: Contribution to journalArticlepeer-review

Original languageAmerican English
JournalThrombosis Research
Volume204
StatePublished - Aug 1 2021

Cite this